Division of Medicine, ICAR-Indian Veterinary Research Institute, Izatnagar, 243122 (UP), India.
Division of Animal Nutrition, ICAR-Indian Veterinary Research Institute, Izatnagar, 243122 (UP), India.
Probiotics Antimicrob Proteins. 2022 Dec;14(6):1054-1066. doi: 10.1007/s12602-021-09862-9. Epub 2021 Oct 22.
The objective of this study was to assess the efficacy of a microencapsulated probiotic as an adjunct therapy in rotavirus-positive diarrhea of neonatal calves that received supportive treatment or supportive along with microencapsulated probiotic treatment, for 5 days. We examined whether microencapsulated Lactobacillus acidophilus NCDC15 probiotic treatment in rotavirus-infected diarrhoetic calves led to faster resolution of diarrhea, amelioration of zinc-copper imbalance, improved the immunoglobulin A and immunoglobulin G, and decreased the inflammatory markers in serum. Calves with rotavirus-positive diarrhea < 4-week age and fecal scores ≥ 2 were randomly assigned into two groups. The supportive along with microencapsulated probiotic treatment significantly (p < 0.05) increased zinc and immunoglobulin A concentrations and decreased copper, tumor necrosis factor-α, and nitric oxide level in serum on days 3 and 5 from pretreatment values; the immunoglobulin G concentration was elevated (p < 0.05) on day 5. The mean resolution time of abnormal fecal score was 5.3 and 3.3 days in supportive treatment and supportive along with microencapsulated probiotic groups, respectively, in log-rank Mantel-Cox test. The calves in the supportive along with microencapsulated probiotic treatment group had faster resolution of diarrhea than supportive treatment group in Dunn's multiple comparisons test. This study demonstrates that supportive treatment along with microencapsulated probiotic administered to naturally rotavirus-infected diarrhoetic calves at onset of diarrhea led to faster resolution of diarrhea, improved zinc and immunoglobulin levels, and decreased the inflammatory parameters in serum of rotavirus-infected diarrhoetic calves.
本研究旨在评估微囊化益生菌作为辅助疗法在接受支持治疗或支持治疗联合微囊化益生菌治疗的新生犊牛轮状病毒阳性腹泻中的疗效,疗程为 5 天。我们研究了微囊化嗜酸乳杆菌 NCDC15 益生菌治疗轮状病毒感染性腹泻犊牛是否能更快地缓解腹泻、改善锌铜失衡、提高免疫球蛋白 A 和免疫球蛋白 G,并降低血清中的炎症标志物。将<4 周龄、粪便评分≥2 的轮状病毒阳性腹泻犊牛随机分为两组。支持治疗联合微囊化益生菌治疗组在第 3 天和第 5 天从预处理值开始,血清中锌和免疫球蛋白 A 浓度显著增加(p<0.05),铜、肿瘤坏死因子-α和一氧化氮水平显著降低(p<0.05);免疫球蛋白 G 浓度在第 5 天升高(p<0.05)。在对数秩 Mantel-Cox 检验中,支持治疗组和支持治疗联合微囊化益生菌治疗组异常粪便评分的平均缓解时间分别为 5.3 和 3.3 天。在 Dunn 多重比较检验中,支持治疗联合微囊化益生菌治疗组的腹泻缓解速度快于支持治疗组。本研究表明,在轮状病毒感染性腹泻犊牛发病时给予支持治疗联合微囊化益生菌治疗,可更快地缓解腹泻,提高锌和免疫球蛋白水平,并降低血清中炎症参数。